Bausch Health Americas, Inc.
Clinical trials sponsored by Bausch Health Americas, Inc., explained in plain language.
-
New pill tested to calm inflamed bowels
Disease control CompletedThis study tested whether a daily oral medication called amiselimod could help control symptoms and reduce intestinal inflammation in adults with mild to moderate ulcerative colitis. For the first 12 weeks, 322 participants were randomly assigned to receive either the real drug o…
Phase: PHASE2 • Sponsor: Bausch Health Americas, Inc. • Aim: Disease control
Last updated Apr 02, 2026 14:57 UTC
-
New acne gel put to the test against leading treatment
Disease control CompletedThis study tested a new topical gel called IDP-126 for treating moderate to severe acne. It directly compared the new gel to a commonly used treatment, Epiduo Forte, and a placebo gel. The 12-week trial involved 686 participants aged 12 and older to see which treatment was more e…
Phase: PHASE2 • Sponsor: Bausch Health Americas, Inc. • Aim: Disease control
Last updated Mar 20, 2026 14:47 UTC
-
New hope for Kids' tummy troubles?
Symptom relief CompletedThis study tested whether a medication called plecanatide could help children and teenagers with irritable bowel syndrome with constipation (IBS-C). Researchers compared different doses of the drug to a placebo (a dummy pill) to see if it increased bowel movements and reduced abd…
Phase: PHASE2 • Sponsor: Bausch Health Americas, Inc. • Aim: Symptom relief
Last updated Mar 31, 2026 12:12 UTC